Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · HHC

HHC in Bosnia and Herzegovina: not individually verified

Not individually verified

We have not confirmed that HHC specifically is scheduled in Bosnia and Herzegovina, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. A route was recorded and rejected through a cannabinoid structural or analogue clause, which is a description rather than text the list prints. The only limb the list actually prints on a cannabinoid entry is an isomer limb, and this compound is a hydrogenated derivative carrying two hydrogen atoms more than tetrahydrocannabinol, so it is not an isomer of it. The substance the limb does reach on its face is delta-8-tetrahydrocannabinol, which shares the named molecule's formula; this one does not. The reading that produced this was made against the list attached to the 2006 Law, as consolidated through Official Gazette 56/26 with the remifentanil move at 58/26, read as at 20 September 2026, and reading it on that date does not rule out a later amendment, so this is an unresolved search result and not a finding that the substance is outside the list.

Confirm directly with Bosnia and Herzegovina’s national drug authority or your own embassy before you rely on anything.

What Bosnia and Herzegovina HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.